Breaking News, Financial News

Financial Report: PAREXEL 3Q10

Consolidated service revenue for the quarter was $227.0 million in Clinical Research Services (CRS), $34.1 million in PAREXEL Consulting and Medical Communications Services (PCMS), and $40.3 million in Perceptive Informatics, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PAREXEL 3Q10 3Q Revenues: $301.4 million (+4%) 3Q Earnings: $15.7 million (+23%) YTD Revenues: $901.6 million (+8%) YTD Earnings: $50.4 million (+76%) Comments: Consolidated service revenue for the quarter was $227.0 million in Clinical Research Services (CRS), $34.1 million in PAREXEL Consulting and Medical Communications Services (PCMS), and $40.3 million in Perceptive Informatics, Inc. Backlog at the end of March was approximately $3.2 billion, up 34%. Results in the quarter we...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters